PATENT CLAIM ANALYSIS

Application Number: 16091674
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "016500"]

Abstract:
The present specification relates to a composition containing a peptide having effects of increasing telomerase activity and extending a telomere, and more specifically, to a composition containing a telomerase-derived peptide, thereby being effective for preventing, alleviating and treating diseases, caused by a decrease in telomerase activity or a reduction in telomere length, and symptoms caused by cell aging or damage. According to one aspect to the present invention, the peptide increases telomerase activity and is effective for extending a telomere, and thus a method for treating diseases induced by an abnormal decrease in telomerase activity and by the length reduction or loss of a telomere and alleviating symptoms caused thereby can be provided.

Claim (Index 13):
The method according to  claim 12 , wherein the disease is one or more selected from a neurodegenerative disorder, a degenerative disease of the nervous system, a degenerative disease of the skeletal system, a degenerative disease of the muscular system, a viral infectious disease, and a genetic disease causing accelerated cell mortality.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 2.12069
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15038269', '15303370', '15539396', '15136353', '14400299']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7397863162253248
- 35 USC 102 Novelty (BERT): 0.5147740491793485
- Combined Prediction Score: 0.7172850895207271
- Mean Citation Score: 260.91548
- Max Citation Score: 267.13126
- Similarity Product: 131.1783094457817

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test